Clinical Trial Update: A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State [Phase 3]

View source ↗

Summary

Update on a Phase 3 clinical trial evaluating dazodalibep in Sjögren's syndrome, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Dazodalibep (dazodalibep)

Snippet

Sponsor: Amgen | Conditions: Sjögren's Syndrome (SS) | Phase 3 | Status: ACTIVE_NOT_RECRUITING